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Abstract 
The activation of the hypothalamic-pituitary-adrenal (HPA) axis during 
inflammation is mediated by prostaglandin E2 (PGE2) produced in the brain. However, 
how PGE2 recruits neuronal mechanisms for HPA axis activation remains unknown. 
Accumulating evidence indicates that GABA-mediated inhibitory synaptic transmission 
plays a major role in the HPA axis regulation. That is, GABAergic transmission 
constitutively constrains the excitability of parvocellular neuroendocrine cells (PNCs) in 
the paraventricular nucleus of the hypothalamus (the HPA axis output neurons); the 
removal from this inhibition (i.e. disinhibition) powerfully activates the HPA axis. My 
thesis examined the actions of PGE2 on GABAergic synaptic transmission to PNCs. Using 
patch clamp electrophysiology in rats hypothalamic slices, I found that PGE2 dose-
dependently attenuated GABAergic transmission onto PNCs. The analysis of synaptic 
property changes revealed that PGE2 decreased the release of GABA from the presynaptic 
terminals whereas it had little, if any, effects on the postsynaptic ionotropic GABA 
receptors. By using pharmacological approaches, I also identified that the EP3 subtype of 
the PGE2 receptor mediated the actions of PGE2 on GABA synapses. Finally, because 
psychological stress is known to influence inflammation-induced HPA axis activation, I 
examined the effects of psychological stress on PGE2-induced GABA synapse plasticity. 
I found that restraint stress impaired PGE2-induced suppression of GABA release. 
Interestingly, however, this modulation by psychological stress was independent of EP3. 
In summary, my thesis provides a plausible mechanism for how PGE2 activates the HPA 
axis during inflammation, and a potential mechanism for its modulation by psychological 
stress. 
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1   Introduction 
1.1   The stress response 
The survival of organisms depends on maintaining a complex dynamic equilibrium 
termed homeostasis (Chrousos, 2009). Any threats to homeostasis, either anticipated or 
real, triggers a set of psychological and physiological changes – commonly called stress 
response – to manage the impending challenges (Johnson et al., 1992; Bains et al., 2015).  
The stress response involves multifaceted changes in both the central nervous 
system (CNS) and multiple peripheral organs. The changes in the CNS include enhanced 
alertness and cognition as well as suppression of some of the vegetative functions including 
appetite, sleep, and reproductive drive. The changes in peripheral functions include 
increased heart rate, respiratory rate, blood pressure, and metabolism (Griffin, 1990; Smith 
and Vale, 2006; Chrousos, 2009).  While these psychophysiological changes associated 
with the stress response are primarily adaptive and promote survival, it is well documented 
that the stress response can have detrimental consequences when it is excessive and/or in 
vulnerable subjects. For example, acute stress can trigger panic attacks, psychotic episodes, 
and allergic reactions such as asthma and eczema. Moreover, chronic stress is a strong risk 
factor for serious disorders including clinical depression, cognitive impairments, and 
metabolic syndrome such as type 2 diabetes mellitus, obesity, and hypertension (Johnson 
et al., 1992; Elenkov and Chrousos, 1999; Chrousos, 2009). Thus, it is important to 
understand how the stress response promotes survival and how deviation from this adaptive 
response may result in detrimental consequences. The focus of this thesis is on the neural 
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mechanisms that regulate the hypothalamic-pituitary-adrenal (HPA) axis, the 
neuroendocrine hallmark of the stress response.    
1.2   The HPA axis 
The HPA axis consists of a hormonal cascade starting from the paraventricular 
nucleus of the hypothalamus (PVN), and then the anterior lobe of the pituitary gland, and 
ultimately the adrenal gland (Figure 1-1). The activation of the HPA axis is initiated by a 
population of neuroendocrine neurons in the PVN that synthesize corticotropin-releasing 
factor (CRF). The cell bodies of these neurons are primarily clustered in a particular 
subdivision of the PVN (the medial parvocellular subdivision) from which they send 
projections to the median eminence. The axonal projections terminate onto the 
hypophyseal portal vessels which lack the blood-brain-barrier; this allows the CRF released 
from the axon terminals to reach the anterior pituitary via the portal circulation. Upon 
activation of CRF type 1 receptors (CRFR1), the anterior pituitary lobe releases 
adrenocorticotropic hormone (ACTH) into the systemic blood stream. Consequently, 
ACTH reaches the adrenal grand, binds to melanocortin type 2 receptors (MC2-R) in the 
adrenal cortex and stimulates the synthesis and release of the glucocorticoids (GCs) from 
the zona fasciculata (Smith and Vale, 2006; Herman et al., 2016). GCs, the ultimate output 
of the HPA axis, induce an array of psychophysiological changes via two types of nuclear 
receptors named mineralocorticoid (MRs) and glucocorticoids (GRs) receptors (de Kloet 
et al., 2005). 
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Figure 1-1. The schematic graph for the hypothalamus-pituitary-adrenal (HPA) 
axis. CRF neurons, the apex of the HPA axis, release CRF (green dots) which triggers 
the secretion of the ACTH form the anterior pituitary gland. ACTH in turn stimulates 
adrenal glands to release glucocorticoids into the blood stream. 
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  The physiological effects of GCs are increased cardiac tone, glucose mobilization, 
enhanced memory and cognition, increased cerebral blood flow, vasoconstriction and 
immune modulation (Sapolsky et al., 2000; Smith and Vale, 2006). In the CNS, both MR 
and GR are expressed in various brain regions, and their functions in the hippocampus and 
amygdala are well documented with relevance to psychobehavioral response to adverse 
events (Lupien et al., 2007; Finsterwald and Alberini, 2014). MR receptors have a tenfold 
higher affinity to GCs than GR and are occupied by baseline (i.e. low) levels of GCs. As 
such, it has been proposed that MR signaling plays a role in preparing the system for the 
initiation of the stress response (Reul and de Kloet, 1985; de Kloet et al., 2005; Finsterwald 
and Alberini, 2014). On the other hand, the lower affinity GRs are generally activated by 
higher stress-associated concentrations of GCs, and therefore drive various stress 
responses. Notably, GRs mediate memory consolidation which could modify future stress 
response (de Kloet et al., 2005; Lupien et al., 2007). Another important aspect of GR 
activation is its roles in the negative feedback regulation of the HPA axis. That is, the 
elevated levels of circulating GCs following stress ultimately act at multiple brain regions 
involved in the HPA axis regulation and terminate the activity of the HPA axis. The PVN 
is one of the key loci of GC-GR signaling suppressing the HPA axis activity (Smith and 
Vale, 2006; Tasker and Herman, 2011).  
Besides their stress-regulatory actions, GCs are potent anti-inflammatory 
mediators.  Indeed, inflammation-induced activation of the HPA axis and the subsequent 
release of GCs are critical fine tuning the inflammatory response. The impairment of GC 
mediated fine tuning of the inflammatory response can result in an uncontrolled 
inflammation such as septic shock (Hench et al., 1949; Sapolsky et al., 2000; Silverman et 
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al., 2005).  This thesis primarily focuses on understanding the neuronal mechanisms by 
which inflammation activates the HPA axis. 
1.3   The PVN 
The PVN is located bilaterally on the side of the third ventricle (Figure 1-2) and 
forms a dense cluster of cell bodies. In rats, it contains approximately 20,000 cells 
occupying about 0.3 mm3 (Swanson and Sawchenko, 1983; Kiss et al., 1991). Importantly, 
the PVN is composed of a highly heterogeneous cell population: it contains different types 
of neuroendocrine neurons that can be classified by the types of neuropeptide expressed, 
the size of the cell bodies, their localization within specific intra-PVN subdivisions, and 
the projection targets (the details will be discussed below). In addition, there are non-
neuroendocrine neurons that send their primary projections to the brainstem and spinal 
cord, and thereby influence the sympathetic tone, e.g. increases heart rate and blood 
pressure (Swanson and Sawchenko, 1983; Stern, 2001).  
1.3.1   Different neuronal subtypes in PVN  
1.3.1.1   Magnocellular neurons 
Magnocellular neurons (MNC) are housed in 3 subdivisions of the PVN (anterior, 
medial and posterior magnocellular subdivisions) and characterized by their relatively 
large cell size (the soma diameters between 20-30 µm). They synthesize both oxytocin 
(OXY) and vasopressin (AVP or antidiuretic hormones, ADH). These cells send axonal 
projections to the neurohypophysis where posterior pituitary hormones are stored and 
released into the blood stream (Swanson and Sawchenko, 1983; Tasker and Dudek, 1991; 
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Benarroch, 2005). OXY is important in inducing the milk-ejection reflex during lactation 
and uterine contraction during labour. In response to blood volume changes, OXY is 
secreted by MNC to regulate body fluids (Leng et al., 1999). AVP has strong antidiuretic 
effects to maintain body fluid volume, osmolarity, and vasoconstriction in response to 
dehydration and hypovolemia (Leng et al., 1999; Amiry-Moghaddam and Ottersen, 2003). 
1.3.1.2   Parvocellular neurons 
The parvocellular neurons are characterized by their relatively smaller cell size (the 
soma diameters between 10-25 µm) and  located within five distinct regions in the PVN 
which are the periventricular, anterior, medial, dorsal and lateral parts of the parvocellular 
subdivisions (Swanson and Sawchenko, 1983; Tasker and Dudek, 1991). Based on their 
projection targets, theses neurons can be further classified into two neuronal subtypes 
including neuroendocrine parvocellular neurons (PNCs) and pre-autonomic (PA) 
parvocellular neurons. PNCs are primarily located medially to the parvocellular division 
of the PVN (Luther et al., 2002). They send projections to the median eminence where they 
release anterior pituitary hormones including CRF, thyrotropin-releasing hormones (TRH), 
and somatostatin (Stern, 2015).  As we discussed in section (1.2), CRF producing neurons 
in the PVN are the principle regulator of the HPA axis which is the focus of this study.  
On the other hand, PA neurons send projections to the brainstem and spinal cord, 
and regulate the autonomic response (Stern, 2001). These neurons are generally positioned 
dorsal and ventral to the parvocellular division of the PVN (Luther et al., 2002). PAs in the 
PVN is a vital center in cardiovascular control, including circadian variation of the blood 
pressure (Cui et al., 2001), blood-volume regulation (Lovick et al., 1993), and the 
 7 
cardiovascular response to psychological stress (Jansen et al., 1995; Stern, 2001; Nunn et 
al., 2011). Moreover, hyperactivity of PAs are implicated in the elevated sympathetic 
activity associated with congestive heart failure (Patel and Zhang, 1996; Patel, 2000). 
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Figure 1-2. The distribution of different types of neurons in the PVN. The 
abbreviations are neuroendocrine corticotrophin-releasing hormone (neCRH), 
neuroendocrine thyrotropin-releasing hormone (neTRH), neuroendocrine 
somatostatin (neSS), neuroendocrine tyrosine hydroxylase (neTH), neuroendocrine 
vasopressin (neVAS), neuroendocrine oxytocin (neOXY), and neuroendocrine 
growth-hormone releasing hormone (neGRH). Adapted from Simmons et al., 2009.  
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Figure 1-3. Electrophysiological properties of PVN neurons.  a) Magnocellular 
neurons exhibit a transient outward rectification characterized by a delay to the first 
spike and a dampening of the membrane charging curve. b) Parvocellular 
neuroendocrine neurons do not express a transient outward rectification and a low 
threshold spike. c) Parvocellular autonomic neurons generate a low threshold spike 
shown as the thick line. Adapted from Tasker et al., 2000. 
c 
a b 
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1.3.2   Electrophysiological properties of different neuronal subtypes in 
the PVN 
With regard to studying PVN neurons using electrophysiology, earlier studies have 
established that different subclasses of PVN neurons have distinct electrophysiological 
properties (i.e. fingerprints) that can be used to identify the neuronal subtypes while 
performing patch-clamp experiments (Tasker and Dudek, 1991; Luther et al., 2000). For 
example, MNCs exhibit, in response to steps of depolarizing current injections, a prominent 
delay to the first action potential with a transient outward rectification (Figure 1-3. a). This 
delay is primarily mediated by A-type voltage-gated potassium channels sensitive to 4-
Aminopyridine (Tasker and Dudek, 1991; Luther et al., 2000). PA neurons can be 
distinguished from other neuronal subtypes in the PVN based on the expression of the low-
threshold spike driven by T-type Ca2+ conductance (Figure 1-3. c, Tasker and Dudek, 
1991; Luther et al., 2000; Stern, 2001). PNCs, on the other hand, are characterized by the 
absence of prominent A-type K+ conductance and low-threshold T-type Ca+ conductance 
(Figure 1-3. b, Luther et al., 2002). 
1.4   Stress-induced activation of the HPA axis 
While a stressor can be any type of sensory information that is perceived as a threat 
to homeostasis, it can be divided into two major categories: physiological and 
psychological stressors. It is generally believed that these different modalities of stressors 
recruit distinct neuronal pathways that ultimately converge into the PVN in order to 
activate the HPA axis (Figure 1-4). For example, psychological stressors, such as exposure 
to a novel environment and restraint stress (two commonly used stress paradigm in rats and 
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mice), recruit several cortico-limbic structures including the prefrontal cortex, 
hippocampus, and amygdala (Herman and Cullinan, 1997; Ulrich-Lai and Herman, 2009). 
These structures do not send direct projection to the PVN but instead connect to a number 
of hypothalamic (e.g. dorsomedial hypothalamus (DMH)) and peri-hypothalamic (e.g. the 
bed nucleus of stria terminalis (BNST)) nuclei which in turn send monosynaptic afferents 
to the PVN neurons (Ulrich-Lai and Herman, 2009; Bains et al., 2015). These multi-layered 
regulatory mechanisms have been proposed to be important for the processing and 
integration of psychological stress that is in essence “anticipatory”. For example, stored 
information from previous stress exposure can modify the subsequent stress response 
leading to sensitization and/or desensitization to particular psychological stressor (Herman 
and Cullinan, 1997; Ulrich-Lai and Herman, 2009; Bains et al., 2015). 
By contrast, physiological stimuli such as hypoxia, inflammation, and pain are real 
(physical) disturbances to the haemostasis. It has been shown that these physiological 
stressors activate the brain stem nuclei that send direct monosynaptic projections to PNCs 
in the PVN (Herman and Cullinan, 1997; Ulrich-Lai and Herman, 2009). Indeed, it has 
been demonstrated that the ascending catecholamineregic (i.e. adrenaline and 
noradrenaline) projections from the brain stem to the PVN (and other hypothalamic and 
supra-hypothalamic structures) are essential for the HPA axis response to physiological 
stressors, such as systemic injection of an inflammatory cytokine interleukin (IL)-1β (Li et 
al., 1996; Buller et al., 2001; Ulrich-Lai and Herman, 2009). However, precise neuronal 
circuits mediating different stressor modalities remain largely unknown.   Moreover, how 
psychological and physiological stressors can be integrated and influence each other at the 
level of the PVN and its upstream cortico-limbic circuits remains unexplored. This thesis 
 12 
aimed to clarify specific synaptic mechanisms that may mediate inflammatory stress 
signals to the PVN PNCs, and investigated how the identified synaptic mechanisms can be 
modulated by psychological stressor with relevance to potential interaction mechanisms 
for psychological and physiological stressors. 
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Figure 1-4. Neuronal circuitry pathways involved in physiological and psychological 
stressors. The abbreviations are prefrontal cortex (PFC), bed nucleus of stria terminalis 
(BNST), corticotropin-releasing factor (CRF), and adrenocorticotropic hormone (ACTH). 
Adopted from Bains et al., 2015. 
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1.4.1   Inflammation and the HPA axis activation 
Inflammation is a complex coordinated set of process that can be initiated in the 
host tissue in response to trauma, bacterial infection, autoimmune diseases and post-
ischemic events (Nathan, 2002; Barton, 2008). The inflammatory response helps the host 
to return to hemostasis state by fighting against the source of inflammation. However, it 
also can cause detrimental consequences, in particular when over-activated, including  
severe collateral tissue damage, septic shock, multi-organ failure, and ultimately death 
(Barton, 2008). The activation of the HPA axis during inflammation, and ensuing anti-
inflammatory actions of GCs provide a critical negative feedback regulation of the 
inflammatory response. An impaired HPA axis function is implicated in septic shock and 
autoimmune diseases such as multiple sclerosis (Kapcala et al., 1995; Wei and Lightman, 
1997; Ruzek et al., 1999; Silverman et al., 2005). 
In order to study the mechanisms of HPA axis activation during inflammation in 
animal models, lipopolysaccharides (LPS) and polyinosinic-polycytidylic (poly I:C) have 
been commonly used (Sapolsky et al., 1987; Gwosdow et al., 1990; Rivest and Rivier, 
1994; Silverman et al., 2005). LPS is the main component of the outer membrane of the 
gram negative bacteria which induces a strong inflammatory response (Alexander and 
Rietschel, 2001). Toll like receptor (TLR)-4 is essential for the recognition of the LPS by 
the immune system (Aderem and Ulevitch, 2000; Medzhitov and Janeway, 2000). Binding 
of the LPS to TLR4 initiates a complex intercellular signaling pathway that leads to the 
production of the key pro-inflammatory mediators such as cytokine IL-1. Next, these 
cytokines mediate their own synthesis and other pro-inflammatory (e.g. IL-6) and anti-
 15 
inflammatory cytokines (e.g. IL-10) (Medzhitov and Janeway, 2000; Konsman et al., 2002; 
Mogensen, 2009).  
Poly I:C is a double-stranded RNA that mimics viral infections and triggers 
immune activation. It has been shown that administration of  poly I:C to the animals 
(rabbits or mice) results in activation of the HPA axis (Milton et al., 1992; Ruzek et al., 
1999). Collectively, inflammation associated with both bacterial and viral infection triggers 
HPA axis activation. Notably, research to date has demonstrated that inflammation-
mediated activation of the HPA axis is modulated mainly by prostaglandin (PG)E2 
(Morimoto et al., 1989; Rivier and Vale, 1991). 
1.5   Prostaglandin E2 and neuroendocrine stress response 
1.5.1   Prostaglandin E2 synthesis 
Prostanoids are a group of fatty acids derived from phospholipids comprising the 
cellular membrane. They consist of PGE2, PGD2, PGI2, PGF2α, and thromboxane A2 
(Sugimoto and Narumiya, 2007). The activation of phospholipase A2 cleaves arachidonic 
acids from the membrane phospholipids. Next, cyclooxygenase (COX) enzyme converts 
arachidonic acids into PGH2 which is subsequently mobilized into the different 
prostaglandins (PGs) by  specific synthases (Narumiya et al., 1999; Kalinski, 2012). There 
are two subtypes of the COX enzyme commonly known as COX1 (constitutive COX 
enzyme) and COX2 (inducible COX enzyme). It has been shown that systemic 
administration of LPS or proinflammatory cytokines, such as IL-1β, induce COX2 
expression in the brain vasculature (endothelial cells and/or perivascular macrophages, 
Breder and Saper, 1996; Cao et al., 1996; Quan et al., 1998). This lead to the prevailing 
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view that circulating afferent inflammatory signals are transduced to PGE2 at the cerebral 
vasculature. Owing to its small size and lipophilic properties, PGE2 in turn diffuses into 
the brain and recruits neural responses that ultimately activate the HPA axis command 
neurons (CRF neurons in the PVN, Schiltz and Sawchenko, 2002,  Jc and Pe,  2003, García-
Bueno et al., 2009).  
PGs exert a wide range of action in various organs and tissues. A large bulk of 
evidence suggests  that among different subtypes of PGs, PGE2 has a key role in regulating 
the HPA axis response to inflammation (Morimoto et al., 1989; Rivier and Vale, 1991). It 
has been shown that indomethacin (COX inhibitor) significantly attenuates the LPS-
induced rise of circulating ACTH, indicating a role of PGs in the activation of the HPA 
axis (Matsuoka et al., 2003; Furuyashiki and Narumiya, 2011). Moreover, microinjection 
of PGE2 into the rat hypothalamus strongly increased the level of the ACTH in the plasma 
suggesting that PGE2’s  actions in the hypothalamus activate the HPA axis (Morimoto et 
al., 1989; Katsuura et al., 1990). In ex vivo brain slices, electrophysiological studies showed 
that application of PGE2 increases the spike frequency of PNCs neurons suggesting that 
local actions of PGE2 (i.e. in a reduced brain slice) excite PNCs (Ferri and Ferguson, 2005, 
Ferri and Ferguson, 2003).  
1.5.2   Prostaglandin E2 receptors and the stress response 
PGE2 exerts its action through four G-protein-coupled receptors (GPCR) EP1, EP2, 
EP3, and EP4 distributed widely throughout the body (Figure 1-5, Sugimoto and 
Narumiya, 2007). Based on the G-protein α subunits, these receptors are divided into three 
categories: 1) EP1 receptors linked with Gαq which lead to an increase in the intracellular 
 17 
Ca2+ level, 2) EP2 and EP4 receptors linked with Gαs which activate adenylate cyclase and 
increase the level of cyclic adenosine monophosphate (cAMP) in the cells, 3) EP3 receptors 
coupled with Gαi/o which decrease the level cAMP (Furuyashiki and Narumiya, 2011). 
PGE2 receptors are involved in both febrile and neuroendocrine stress response to sickness 
model (LPS administration, Furuyashiki and Narumiya, 2009). Using mice lacking PGE2 
receptors subtypes, it has been reported that LPS-induced ACTH release was abolished in 
mice deficient in either EP1 or EP3 receptors. In addition, the number of neurons 
expressing c-Fos (a marker of neuronal excitation) was decreased in the PVN in mice 
lacking either one of these two receptors (Matsuoka et al., 2003b; Furuyashiki and 
Narumiya, 2011). These findings indicate that PGE2 acting via EP1 and EP3 receptors 
plays a crucial role in the activation of the HPA axis in response to systemic inflammation. 
Additionally, results from in situ hybridization and immunohistochemistry revealed that 
EP1 and EP3 are expressed in cell bodies and axonal terminals of  PVN neurons, 
respectively (Nakamura et al., 2000; Oka et al., 2000). The existence of both EP1 and EP3 
receptors in  PVN support the findings that these receptors might be involved in modulating 
the HPA axis response to inflammation. However, it remains to be examined exactly how 
PGE2 contributes to the activation of the HPA axis through EP1 and EP3 receptors. The 
mechanism by which PGE2 activates PNC remains not fully understood. Earlier studies 
indicated that PGE2 modulates GABA inputs to PNC and alters their excitability (Ferri and 
Ferguson, 2003; Ferri et al., 2005). 
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Figure 1-5. Prostaglandin E2 receptors subtypes. EP1 receptors coupled with Gq 
which increase the intracellular Ca2+ level. EP2 and EP4 receptors linked with Gsα 
which increase the level of cAMP in cells. EP3 receptors coupled with Giα which 
decrease the level cAMP in cells. Adopted from Furuyashiki et al., 2011. 
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1.6    γ-aminobutyric acid (GABA)-mediated synaptic 
transmission 
1.6.1    GABA synthesis and function 
The amino acid γ-aminobutyric acid (GABA) have been discovered over half a 
century ago as the major inhibitory neurotransmitter in the mammalian nervous system 
(Owens and Kriegstein, 2002). This neurotransmitter which was originally called Factor Ι, 
identified in the mammalian brain extracts that inhibited the formation of the impulse by 
stretch receptors neurons in crayfish (Elliott and Flow, 1956; Owens and Kriegstein, 2002). 
Later on, this substance was identified as GABA (Bazemore et al., 1957). It has been shown 
that approximately between one fifth and one sixth of synapses in the brain release GABA 
(Somogyi et al., 1998). GABA is primarily produced form L-glutamic acid through the 
action of either one of the two glutamic acid decarboxylase (GAD) enzymes commonly 
known as GAD 65 and GAD 67 each of which has distinct enzymatic functions and cellular 
distributions (Kaufman et al., 1991; Martin and Rimvall, 1993; Owens and Kriegstein, 
2002). A vesicular neurotransmitter (VGAT) is responsible for loading GABA into 
synaptic vesicles. The elevation of the intracellular Ca2+ within the synaptic terminals, 
resulting for example from the arrival of an action potential, triggers the fusion of the 
synaptic vesicles with the cell membrane and consequently neurotransmitter release into 
the synaptic cleft. A class of plasma-membrane GABA transporter (GATs) is involved in 
the rapid removal of the neurotransmitter from the synaptic clefts (Owens and Kriegstein, 
2002). Subsequently, GABA is metabolized to succinic acid by GABA transaminase 
(GABA- T, Martin and Rimvall, 1993; Tao et al., 2006). 
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1.6.2   GABA receptors 
GABA exerts its actions through the activation of two main types of receptors 
which are the ionotropic GABAA receptors, as well as the metabotropic GABAB receptors 
(Wu and Sun, 2015). Among these receptors, GABAA receptor is predominantly involved 
in fast synaptic transmission in the CNS, and is the focus of this thesis as the target of PGE2 
actions in the PVN.  
1.6.2.1   GABAA receptors 
GABA A receptors are ligand-gated ion channels which primarily conduct chloride 
(Cl-). The opening of the Cl- channels allows the flow of Cl- across the cell membrane that 
follows its electrochemical gradient. In adult neurons, low levels of intracellular Cl- 
(relative to extracellular Cl-) causes influx of Cl- near the resting membrane potential (i.e. 
-60 mV) and thus causes hyperpolarization of the post synaptic membrane (Owens and 
Kriegstein, 2002; Wu and Sun, 2015). However, in developing neurons, activation of the 
GABAA receptors could result in depolarization which is due to higher concentration of 
the Cl- within the neuron (Ben-Ari, 2002). GABAA receptor is a heteropentameric ion 
channel which consists of 19 different subunits commonly known as α1-6, β1-3, γ1-3, δ, 
ε, θ, π, and ρ1-3 (Luscher et al., 2011). Different subunits combinations determine distinct 
GABAA receptors in terms of function, structure, and pharmacology (Olsen and Sieghart, 
2008; Luscher et al., 2011).  
1.6.3   Roles of GABA in the PVN and the HPA axis  
The neuroendocrine CRF neurons in the PVN receive  dense GABAergic inputs 
(Cullinan et al., 2008). Dual hybridization histochemical studies demonstrated that CRH 
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neurons express various GABAA receptors subunits including  α1-2, and β1-3 (Cullinan 
and Wolfe, 2000; Cullinan et al., 2008). Notably, electron microscopic studies have shown 
that nearly half (46.2%) of the all synaptic terminals in the medial parvocellular subdivision 
of the PVN (where neuroendocrine CRF neurons concentrate) are GABAergic, indicating 
that GABA is one of the main neurotransmitters regulating the HPA axis (Miklós and 
Kovács, 2002). A substantial body of literature suggests that the GABA-mediated 
inhibition tonically constrains CRF neuron excitability and as a consequence the HPA axis 
activity (Makara and Stark, 2004; Cullinan et al., 2008). For example, local microinjection 
of the GABAA receptors antagonist (bicuculline) into the PVN of unstressed rats robustly 
induced c-Fos expression in the medial parvocellular subdivision of the PVN (Cole and 
Sawchenko, 2002), indicating that  removal from tonic GABA-mediated inhibition is one 
mechanism to activate the HPA axis.  
Interestingly, it has been shown that following acute restraint stress the inhibitory 
action of GABA on PVN neurons was remarkably reduced. This loss of GABAergic 
inhibition following stress was due to the down regulation of the KCC2 (the K/Cl 
transmembrane transporter) leading to subsequent change in intercellular Cl- concentration 
and depolarizing shifts in the reversal potential of GABAA R-mediated currents (Hewitt et 
al., 2009; Sarkar et al., 2011; Maguire, 2014). 
Combining retrograde tracer and immunohistochemical method, it has been 
identified that anterior paraventricular nucleus, anterior perifornical area (this region is part 
of the bed nucleus of stria terminalis), peri supra-optic area, anterior hypothalamic, and 
dorsomedial hypothalamic nucleus are potential origins for GABAergic projections to the 
PVN (Roland and Sawchenko, 1993; Cullinan et al., 2008). 
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1.7   Rationale and Aims 
1.7.1   Rationale 
There is a considerable amount of evidence suggesting that PGE2 plays a key role 
in activation of the HPA axis in response to inflammation. However, little is known about 
how PGE2 increases the excitability of the CRF neurons in the PVN. Using patch clamp 
electrophysiology in ex vivo slices, it has been shown that application of PGE2 increases 
the firing frequency of PVN neurons including PNCs. Notably, the results from the same 
study showed that bath application of PGE2 decreases the frequency of the IPSPs in PNCs. 
Moreover, application of the bicuculline, a GABAA receptors antagonist, into the PVN 
containing brain slices mimics PGE2-mediated excitation of the PNCs (Ferri et al., 2005). 
Together, these observations suggest that PGE2 blocks GABAergic inputs onto PNCs and 
consequently activates HPA axis. However, the precise mechanisms by which PGE2 
modulates GABAergic inputs onto PNCs remains to be clarified. Therefore, my thesis 
sought to investigate the synaptic mechanisms by which PGE2 modulates GABAergic 
synaptic transmission onto PNCs with relevance to the roles of PGE2 in HPA axis 
activation. Moreover, it has been shown that prior exposure to psychological stress 
significantly increases the HPA axis response to inflammation (Jd et al., 2002). These 
finding indicate that psychological stress could modulate the way PGE2 drives HPA axis 
activation. My thesis explored the impact of psychological stress on the effects of PGE2 
on GABAergic synaptic transmission onto PNCs.  
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1.7.2   Aims 
Aim 1: To investigate the synaptic mechanism by which PGE2 activates PNCs. 
An earlier electrophysiological study has demonstrated that PGE2 increases the 
excitability of the PNCs. Importantly, this effect was mediated through suppression of the 
GABAergic synaptic transmission (Ferri and Ferguson, 2003; Ferri et al., 2005). However, 
the results from this study did not illustrate whether the effect of the PGE2 on GABAergic 
inputs is presynaptic or postsynaptic. In order to extend this earlier finding, I performed 
patch clamp electrophysiology to tease out the precise locus of PGE2 actions on 
GABAergic transmission. 
Aim 2: To elucidate which receptor of PGE2 modulates GABA ergic synaptic 
transmission. 
LPS-induced activation of the HPA axis is impaired in EP1 and EP3 deficient mice 
suggesting that these two receptors might have a crucial role in the activation of the HPA 
axis (Matsuoka et al., 2003). Among these two receptors, EP3 is primarily coupled with 
Gαi/o signaling that can decrease neurotransmitter releases including GABA in many 
synapses (Atwood et al., 2014). Thus, I hypothesized that EP3 receptors mediates PGE2-
induced suppression of the GABA release.  
 
 
  
 24 
 
 
 
  
b a 
Figure 1-6. The schematic diagram of inflammation induced activation of the 
HPA axis. A) Inflammation activates the HPA axis, which in turn attenuates 
inflammatory responses. B) My hypothetical model that PGE2 activates HPA axis 
through inhibition of GABAergic inputs onto CRH neurones.  
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Aim 3: To examine whether psychological stress alter PGE2-mediated HPA axis 
activation. 
No studies to date have investigated the effect of the psychological stress on PGE2-
mediated activation of the HPA axis at synaptic and molecular levels. Thus, I hypothesized 
that exposure to psychological stress alters the effects of PGE2 on GABAergic synaptic 
transmission onto PNCs. 
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2   Material and Methods 
2.1    Animal handling and stress  
All the experiments involving the use of animals were approved by institutional 
care and use committee of the University of the Western Ontario in accordance with the 
guideline of the Canadian Counsel on Animal care. Experiments were performed using 
male Sprague Dawely rats (Charles River Laboratories, Quebec, Canada) aged between 25 
and 45 days. After being shipped from the supplier, the animals were acclimatized to the 
institutional facility for minimum 5 days before any experiments. The animals were kept 
in a 12 h/12 h light–dark cycle (lights on at 7:00 AM). Food and water were provided ad 
libitum. Every effort was made to prevent causing any unnecessary distress to the animals.  
For the stress experiments, rats were confined within a well-ventilated Plexiglas cylinders 
that restricts their movement for 30 min. Restraint was performed during the light phase, 
between 12:00 and 1:00 PM, for either 1 or 5 consecutive days. Immediately after the last 
immobilization stress, animals were deeply anesthetized with isoflurane and decapitated to 
prepare brain slices. 
2.2   Slice preparation 
The brain was quickly removed and immersed into ice-cold slicing solution (95% 
O2, 5% CO2 saturated) containing (in mM: NaCl 87, KCl 2.5, NaHCO3 25, MgCl2 7, 
NaH2PO4 1.25, glucose 25, and sucrose 75). Coronal hypothalamic slices (300 µm) were 
prepared using a vibratome (VT1200s, LEICA). Slices containing the PVN were identified 
based on the macroscopic features and placed into a slice camber filled with artificial 
cerebrospinal fluid (aCSF) containing (in mM; NaCl 126, KCl 2.5, NaHCO3 25, MgCl2 
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1.2, NaH2PO4 1.2, glucose 11, and CaCl2 2.5) constantly bubbled with 95% O2, 5% CO2. 
The slice chamber was maintained at 35 °C for 30 min for the recovery of slices, and 
thereafter kept at room temperature for a longer storage of slices. Before the recording 
process, the slice was transferred to the recording chamber constantly perfused with aCSF 
(30°°C, saturated with 95% O2, 5% CO2) at a flow rate of 1-2 ml per min. 
2.3   Electrophysiology  
All recordings were performed using whole-cell patch clamp configuration. Under 
an infrared differential interference contrast microscope (BX51WI, Olympus), PVN 
neurons were visually identified based on their morphology, and PNCs were selected based 
on their location, morphology and electrophysiological characteristics in a current-clamp 
configuration (Tasker and Dudek, 1991). Borsosilicate glass microelectrode (2-4 MΩ) 
were pulled using a Flaming/Brown type micropipette puller (P1000, Sutter Instrument, 
CA, USA) and filled with intracellular solution consisted of (in mM: K-gluconate 123, 
NaCl 8, EGTA 1, HEPES 16, MgCl2 2, K2ATP 4, and Na3GTP 0.3). The osmolality of the 
intracellular solution was between 283 and 289 mOsm. Moreover, its pH was adjusted 
between 7.2 and 7.4 by using KOH. For the whole cell recording, a gigaseal was obtained 
followed by patch rupture, which was achieved by applying a brief suction.  
In the voltage-clamp experiments, PNCs were clamped at -68 mV and recordings 
were obtained at 30°C. During the whole process of recording, an AMPA kainate receptor 
antagonist, 6,7-dinitroquinoxaline-2,3-dione (DNQX; 10 µM, Tocris Bioscience) was 
perfused constantly to isolate fast GABAA receptor-mediated inhibitory postsynaptic 
currents (IPSCs). In experiments where TTX (0.5 µM) was added, PGE2 was not applied 
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until action potentials were completely blocked. Access resistance was monitored every 5 
min, and recordings were discarded if the value exceed 20 MΩ or changed more than 20% 
from the baseline.  
A glass electrode filled with aCSF was placed medial to the recorded neuron to 
evoke a pair of IPSCs 50 ms apart and at the rate of 0.2 Hz. Using this electrode, I 
stimulated GABAergic synapses projecting to the PVN. The duration of the stimulation 
was 1 ms and the intensity of the stimulation was between 6 to 9 V. As I discussed in 
section (1.6.3) the potential origins of these projections are anterior paraventricular 
nucleus, anterior perifornical area (this region is part of the bed nucleus of stria terminalis), 
peri supra-optic area, anterior hypothalamic, and dorsomedial hypothalamic nucleus 
(Roland and Sawchenko, 1993; Cullinan et al., 2008). Indeed, these inputs are not 
composed of any pathway or neuronal tract. Instead, these GABAergic terminals are 
intermingled with neurons in the PVN.  
2.4   Drugs 
     PGE2 (cat#: 14010 ), Sulprostone (cat#: 14765 ), L-798,106 (cat#: 3342) were 
obtained from Cayman Chemical (city, USA), dissolved in 100% ethanol and kept at -20°C 
as aliquot, and diluted to appropriate concentration as required. The maximum 
concentration of ethanol in the final working solution was 0.2%. TTX (cat#: T-550) was 
obtained from Alomone labs (Jerusalem, Israel). 
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2.5   Data collection, analysis and statistics 
 Recordings were amplified using Multiclamp 700B (Molecular Devices), low pass 
filtered at 1 kHz, and digitized at 10 kHz with a Digidata 1440 A (Molecular Devices). 
Signals were recorded (pClamp 10.1, Molecular devices) and stored in the computer for 
offline analysis. Evoked IPSC (eIPSC) amplitudes were calculated by subtraction of peak 
synaptic currents from pre-stimulation baseline currents. Spontaneous IPSCs were 
analyzed using MiniAnalysis (Synaptosoft) and confirmed as synaptic events by visual 
analysis. Data was normalized and presented as a percentage of baseline value (0-5 min 
before treatment). Post-treatment values were examined 5 to10 min after application of the 
drugs. Frequency and amplitude of eIPSCs, paired-pulse ratio (amplitude of 2nd eIPSC/1st 
eIPSC), and coefficient of variation (CV, standard deviation/mean) were analyzed for 5 
minute bins. Data was presented as mean ± s.e.m. Statistical significance was tested using 
parametric t-test in all experiments. To analyze the correlation between two variables, 
linear regression analysis was applied. A probability values < 0.05 was considered 
statistically significant. All statistical analysis were performed using the GraphPad Prism 
7 (GraphPad Software Inc., CA, USA). 
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3   Results 
3.1   PGE2 inhibits GABAergic synaptic transmission onto 
PNCs 
My hypothesis was that PGE2 attenuates GABAergic synaptic transmission onto 
PNCs. To test this hypothesis, I examined the effects of PGE2 on GABAergic inhibitory 
postsynaptic currents (IPSCs) in a whole-cell voltage clamp configuration. Consistent with 
previous data, I found that bath application of PGE2 (10 µM for 5 min) robustly decreased 
the amplitude of eIPSCs (54.94 ± 8.8 % of the baseline, p = 0.001, n = 9, Figure 3-1 a, b). 
This finding indicates that the release from GABA-mediated inhibition could be one 
possible mechanism by which PGE2 modulates HPA axis activation. Notably, the effect of 
PGE2 was long-lasting, persisted for the duration of the stable recording >25 min after the 
washout. PGE2 dose-dependently (0.01-100 µM) attenuated eIPSCs with the maximum 
effect reaching at 10 µM (Figure 3-1  d).  
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Figure 3-1 PGE2 decreases the amplitude of eIPSCs. (a)  Sample traces of eIPSC 
before (black) and after (red) PGE2 application recorded from rats hypothalamic slices. 
(b) Representative time-course of eIPSC amplitude. The horizontal bar indicates the 
time of PGE2 application (c) Summary time-course of eIPSCs amplitude. PGE2 
significantly decreased the amplitude of eIPSCs (0-5 min vs. 10-15 min, p = 0.001, n 
=9 ). The horizontal line represents the time of PGE2 application. Data are mean ± s.e.m. 
(d) Dose-response relationship for PGE2 inhibition of IPSCs. The EC50 is calculated to 
be 4.55 ⋅  10 -6 M. 
 
a b 
c d 
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3.2   PGE2-mediated GABA synapse depression involve 
presynaptic mechanisms 
Our finding demonstrated that PGE2 attenuated GABAergic synaptic transmission 
to PNCs. PGE2 could modulate this effect either through presynaptic mechanisms 
(decrease in probability of the neurotransmitter release) or postsynaptic mechanisms 
(modulation of the post synaptic receptors function) as illustrated in Figure 3-2. To tease 
out the locus of the PGE2-induced depression of GABAergic synaptic transmission, I 
analyzed the concomitant changes in the paired-pulse ratio (PPR) and coefficient of 
variation (CV) of the eIPSCs (Figure 3-3 a). According to a widely-accepted model of 
synaptic transmission, if the depression of eIPSC involves a decrease in the probability of 
the neurotransmitter release (Pr), it should be accompanied by an increase in PPR as well 
as a decrease in 1/CV2 (Table 3-1, Korn and Faber, 1991; Branco and Staras, 2009). In line 
with this prediction, PGE2 significantly increased the PPR (136.6 ± 10.75 % of baseline, 
p = 0.0092, n=9). Similarly, PGE2 decreased 1/CV2 (45.06 ± 11.4 % of baseline, p = 
0.0014, n = 9). We also plotted the changes in PPR and 1/CV2 against eIPSCs amplitude 
in each individual cell to investigate more closely the relationship between PPR, 1/CV2, 
and GABA synapse depression (Figure 3-3 b).  Our data showed that there is a strong linear 
negative correlation between PPR and eIPSCs (R2=0.32, p=0.0001), and also a positive 
linear correlation between 1/CV2 and eIPSCs amplitude (R2=0.59, p< 0.0001).  
The analysis of spontaneous IPSCs (sIPSCs) revealed that that PGE2 (10 µM) 
decreased the frequency of  sIPSCs (38.12 ± 6.4 % of the baseline, p = 0.0002, n = 6, 
Figure 3-4 a, d). Again, this observation is consistent with the decrease in Pr from the 
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presynaptic terminals. By contrast, PGE2 did not affect the mean amplitude of the sIPSCs 
(99.61± 6.2 % of the baseline, p = 0.9, n = 6, Figure 3-4 b, d), indicating that PGE2 did 
not change postsynaptic receptor function. Table 3-1 summarizes the changes of 
biophysical parameters associated with the PGE2-induced eIPSC suppression. The changes 
in these parameters could determine whether PGE2 modulates GABAergic synaptic 
transmission through presynaptic or post synaptic mechanisms. Collectively, our finding 
showed that application of the PGE2 was accompanied by an increase in PPR and a 
decrease in 1/CV2 and sIPSCs frequency. As indicated in Table 3-1, these changes 
represent the decrease in Pr from the presynaptic terminals. 
Next, in order to examine whether or not the effect of PGE2 is action potential-
dependent, I applied tetrodotoxin (TTX, 0.5 µM) to block voltage-gated Na+ channels. Our 
results showed that, in presence of TTX, PGE2 (1-10 µM) significantly decreased the 
frequency of miniature IPSCs (mIPSCs) (17.6 ± 4.05 % of baseline, p <0.0001, n = 5, 
Figure 3-4 d) without showing any significant effect on the average amplitude (101 ± 4.5 
% of baseline, p = 0.8, n = 5). These findings indicate that the inhibitory effect of PGE2 on 
GABAergic synaptic transmission is through action-potential independent mechanisms.  
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Figure 3-2. Potential mechanisms for PGE2-induced suppression of the GABA synapse. 
a) PGE2 could decrease the probability of the neurotransmitter release. b) PGE2 could 
modulate the post synaptic receptors. c) PGE2 could shut down the synaptic transmission by 
both inhibiting the neurotransmitter release and eliminating the post synaptic receptors. 
 
a b 
PGE2  PGE2 PGE2 
c 
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 PPR 1/CV2 sIPSCs amplitude 
sIPSCs 
frequency 
Pr     
n     
q     
Table 3-1. Changes of synaptic properties associated with different types 
of synaptic plasticity. The table illustrates how the decrease in probability of 
release (Pr), numbers of synapses (n), quantal size (q) change paired pulse ratio 
(PPR), 1/CV2, spontaneous Inhibitory Postsynaptic Currents (sIPSCs) 
frequency, and amplitude. 
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Figure 3-3. PGE2 application is accompanied by a decrease in neurotransmitter 
release probability. (a) Summary time-course of amplitude (white), PPR (red), and 
1/CV2 (blue) of eIPSCs recorded in slices contained PNCs from Sprague Dawley 
rats. The horizontal bar indicates the time of PGE2 application. (b) Plots of 1/CV2 
(blue) and PPR (red) versus amplitude after PGE2 application recorded from PNCs. 
The blue and the red solid lines represent the best fit linear regression for 1/CV2 (r2 
= 0.59, P < .0001) and PPR (r2 = 0.32, P = 0.0001), respectively. 
a b 
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Figure 3-4. PGE2 does not change the quantal amplitude. (a) Sample traces of sIPSC 
before (black) and after (red) PGE2 application recorded in rats hypothalamic slices. (b) 
Superimposed recording of 5 min of sIPSC before (black) and after (red) PGE2 application. 
Solid traces depict the average of sIPSCs before (black) and after (red) bath application of 
PGE2. (c) Representative time-course of sIPSCs amplitude (blue square) and frequency (red 
bar). The horizontal bar illustrates the time of PGE2 application. (d) Summary time-course 
of normalized sIPSC amplitude (blue, p = 0.9, n = 6), frequency (red, p = 0.0002, n = 6), and 
frequency with TTX (gray, p <0.0001, n = 5). The statistical evaluation was parametric t-test 
for post-treatment (10-15 min) versus pre-treatment (0-5 min) data. Data are mean ± s.e.m. 
a b 
c d 
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3.3   PGE2-EP3 signaling modulates GABA release onto PNCs  
PGE2 acts through four GPCRs receptors EP1-4 (Sugimoto and Narumiya, 2007). 
It has been shown that LPS-induced activation of the HPA axis is impaired in EP1 and EP3 
deficient-mice suggesting that both EP1 and EP3 receptors might be involved in ACTH 
secretion in response to LPS (Matsuoka et al., 2003). Immunohistochemistry and combined 
in situ hybridization histochemistry studies have shown EP3 expression in the 
hypothalamus (Ek et al., 2000; Nakamura et al., 2000). Moreover, the EP3 receptor is 
primarily coupled to the Gi/oα-protein subunit which can decrease the probability of 
neurotransmitter release from presynaptic terminals (Atwood et al., 2014). Combining 
these evidences, we hypothesized that EP3 is responsible for the PGE2-induced GABA 
synapse depression. To address the hypothesis, we applied EP3 agonist (sulprostone 1 µM). 
Similar to PGE2, bath application of sulprostone for 5 min resulted in a reduction of the 
eIPSCs amplitude (60.7 ± 9.6% of baseline, p = 0.0036, n = 9, Figure 3-5 a, b, c). 
Furthermore, the depression of eIPSCs was accompanied by an increase in PPR and a 
decrease in 1/CV2, suggesting the decrease in Pr is similar to the case of PGE2. We also 
examined the effect of sulprostone on the frequency and amplitude of the sIPSCs, and 
found that sulprostone decreased the frequency (47% ± 15 of baseline, p < 0.05, n = 5) 
without changing the mean amplitude of sIPSCs  (95% ± 4.9 of baseline, p = 0.4, n = 5, 
Figure 3-6 a, b, c).  
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Figure 3-5. EP3 agonist mimics the effect of PGE2. (a) Individual (thin line) and 
average (solid line) trace of eIPSC before (black) and after (blue) sulprostone (EP3 
agonist, 1 µM) application recorded from rat hypothalamic slices. (b) Representative 
time-course of eIPSCs amplitude. The time of Sulprostone application is shown by 
horizontal bar. (c) Summary time-course of normalized eIPSC amplitude (blue), 1/CV2 
(purple), and PPR (red). Sulprostone significantly decreased the amplitude of eIPSCs (0-
5 min vs. 10-15 min, p = 0.0036, n = 9). Data are mean ± s.e.m. (d) Plots of normalized 
1/CV2 (red), and PPR (blue) versus amplitude 5 to 10 min after Sulprostone application. 
The blue and the red solid lines represent the best fit linear regression for 1/CV2 and PPR, 
respectively.  
a b 
c d 
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Figure 3-6. EP3 agonist mimics the effect of PGE2. (a) Sample traces of sIPSCs before 
(black) and after (blue) application of the EP3 agonist recorded from PNCs. (b) Summary 
time-course of the sIPSCs frequency. Sulprostone significantly decreased the frequency of 
sIPSCs (0-5 min vs. 10-15 min, p = 0.018, n = 5). Data are mean ± s.e.m. (c) Summary 
time-course of amplitude of the sIPSCs. Sulprostone did not change the amplitude of 
sIPSCs (0-5 min vs. 10-15 min, p = 0.4, n = 5). The horizontal bar indicates the time of 
the sulprostone (EP3 agonist) application. Data are mean ± s.e.m. 
a 
b 
c 
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Next, as a complementary experiment, I examined the effect of an EP3 antagonist 
(L-798, 106, 100µM) on PGE2-induced suppression of eIPSCs. For this part of the 
experiment, PGE2 was bath applied in the presence of the L-798, 106 (EP3 antagonist). I 
found that L-798, 106 (100 µM) completely blocked the effect of the PGE2 (1 µM) (110 ± 
8.4 % of baseline, p = 0.247, n = 8, Figure 3-7 a, b, c). Furthermore, in the presence of L-
798, 106, PGE2 did not change PPR (106 ± 6.6 % of baseline, p= 0.38) or 1/CV2 (104 ± 
14.02 % of baseline, p=0.73). Moreover, when sIPSCs were examined, L-798, 106 did not 
change the frequency (116.9  ± 14.8 % of baseline, p = 0.3, n = 6) or the amplitude (102.5 
± 3.5 % of baseline, p = 0.51, n = 6, Figure 3-8 a, b, c). Collectively, my data indicate that 
PGE2 suppresses GABAergic synaptic releases through pre-synaptic EP3 receptors. 
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Figure 3-7. Ep3 antagonist blocks the effect of PGE2. (a) Individual (thin line) and average 
(solid line) trace of eIPSC before (black) and after (green) EP3 antagonist (L-798 106, 100µM) 
+ PGE2 application. (b) Representative time-course of eIPSCs amplitude.(c) Summary time-
course of normalized eIPSCs amplitude (green), 1/CV2 (purple), and PPR (pink). Application of 
PGE2 + EP3 antagonist did not decrease the amplitude of eIPSCs (0-5 min vs. 10-15 min, p = 
0.274, n = 8). Data are mean ± s.e.m. (d) Percent change in eIPSC amplitude from the baseline 
after application of the PGE2 (red), sulprostone (blue), and EP3 antagonist (L-798 106, green).  
a b 
c 
d 
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Figure 3-8. Ep3 antagonist blocks the effect of PGE2. (a) Sample trace of sIPSCs before 
(black) and after (green) PGE2 + EP3 antagonist (L 798 106) application. (b) Summary time-
course of frequency (p = 0.3,  of the sIPSCs. PGE2 + EP3 antagonist did not change the frequency 
of sIPSCs (0-5 min vs. 10-15 min, p = 0.3, n = 6). (c) Summary time-course of the sIPSCs 
amplitude. PGE2 + EP3 antagonist did not change the amplitude of sIPSCs (0-5 min vs. 10-15 
min, p = 0.38, n = 6). Data are mean ± s.e.m. 
a 
b 
c 
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3.4   Psychological stress impairs PGE2-mediated inhibition of 
GABA release. 
In addition to inflammation, psychological stress is another modality of stress that 
strongly activates the HPA axis. Studies to date have shown that the sensitivity of the HPA 
axis to inflammation could be modulated by preceding exposures to psychological stress. 
For example, it has been reported that prior exposure to unescapable tail shock significantly 
increases HPA axis response to LPS injection in rats (Jd et al., 2002). Considering that both 
modalities of stress (physiologic and psychologic) ultimately recruit the same 
neuroendocrine stress response, one possibility is that psychological stress may modulate 
the sensitivity of afferent synapses onto PNCs to inflammatory signals. Thus, I asked 
whether psychological stress modulates the effects of PGE2 on GABAergic synaptic 
transmission onto PNCs. In order to test this, the rats were subjected to restraint stress for 
30 min, and immediately sacrificed to produce acute brain slices. I found that, in slices 
from stressed rats, PGE2 did not significantly affect the amplitude of the eIPSCs (p > 0.05, 
n = 9, Figure 3-9 a, b, c), indicating that PGE2-induced suppression of GABA release is 
lost following acute stress. Interestingly, however, sulprostone (1 µM, EP3 agonist) still 
decreased the amplitude of the eIPSCs (74.24 ± 8.5% of baseline, p = 0.02, n = 6,  Figure 
3-10. a, b, c), similar to what I observed in naïve animal. This indicates that following 
acute psychological stress, EPs other than EP3 are recruited to counteract the EP3-mediated 
suppression of GABA release.  
Next, I examined the effects of sub-chronic psychological stress on PGE2-mediated 
GABA release suppression. To this end, I obtained acute brain slices from rats subjected 
to daily 30 min restraint stress for 5 consecutive days, and repeated the same experiments. 
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Similar to the case of acute stress, I found that PGE2-induced eIPSCs was impaired (78.04 
± 13.2% of baseline, p = 0.14, n=8, Figure 3-11 a, b, c) a result similar to the data from 1 
day stress experiments. Furthermore, application of the EP3 agonist decreased the 
amplitude of eIPSCs (74.24 ± 11.28% of baseline, p = 0.08, n = 5, Figure 3-12 a, b, c). 
Collectively, our data demonstrated that that both single and repeated 
immobilization stress impair PGE2-induced suppression of the GABA release suggesting 
that psychological stress may decrease the excitatory effect of the PGE2 on PNCs (Figure 
3-13 a). However, even though there was a trend towards reduced EP3 receptor function, 
it was not significantly different from naïve animals. Our findings did not show any 
significant differences between the effect of single acute and repetitive restraint stress 
(Figure 3-13 b). Interestingly, we have observed variability in neuronal responses to the 
PGE2 application, meaning that some synapses exhibit potentiation while other showed 
depression. One likely interpretation of these findings is that after psychological stress 
other receptors might be involved in PGE2-induced potentiation of the GABA release that 
masks EP3-mediated depression. 
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Figure 3-9. Acute stress modulates PGE2-mediated suppression of GABA release. (a) 
Individual (thin line) and average (solid line) traces of eIPSCs before (black) and after (pink) 
application of PGE2 recorded from stressed animal. (b) Representative time-course of eIPSCs 
amplitude. The horizontal bar represents the time of PGE2 application. (c) Summary time-
course of eIPSCs amplitude (pink), PPR (red), and 1/CV2 (purple). PGE2 did not change the 
amplitude of eIPSCs (0-5 min vs. 10-15 min, p > 0.05, n = 9). The horizontal bar shows the 
time of PGE2 application. Data are mean ± s.e.m. 
a 
b c 
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Figure 3-10. Acute stress does not modulate EP3 -mediated suppression of GABA release. 
(a) Individual (thin lines) and average (solid line) traces of eIPSCs before (black) and after 
(purple) sulprostone (EP3 agonist) application recorded from stressed animal. (b) 
Representative time-course of eIPSCs amplitude. The bar indicates the time of sulprostone 
(EP3 agonist) application. Data are mean ± s.e.m. (c) Summary time-course of eIPSCs 
amplitude (purple) p = 0.02, n = 6), PPR (red), and1/CV2 (light purple). Sulprostone 
significantly decreased the amplitude of eIPSCs (0-5 min vs. 10-15 min, p = 0.02, n = 6). The 
horizontal bar represents the time of sulprostone (EP3 agonist) application. Data are 
mean±s.e.m. 
b 
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Figure 3-11. Chronic stress impairs PGE2-mediated suppression of GABA release. 
(a) Individual (thin line) and average (solid line) traces of eIPSCs before (black) and 
after (dark brown) application of PGE2 recorded from stressed animal. (b) 
Representative time-course of eIPSCs amplitude. The horizontal bar represents the time 
of PGE2 application. (c) Summary time-course of eIPSCs amplitude (dark brown), PPR 
(red), and 1/CV2 (light purple). PGE2 did not change the amplitude of the eIPSCs (0-5 
min vs. 10-15 min, p = 0.14, n = 8). The horizontal bar shows the time of PGE2 
application. Data are mean ± s.e.m. 
a 
b c 
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Figure 3-12. EP3 receptor suppresses GABAergic synaptic transmission following 
chronic stress. (a) Individual (thin lines) and average (solid line) traces of eIPSCs 
before (black) and after (light brown) application of the sulprostone (EP3 agonist) 
recorded from stressed animal. (b) Representative time-course of eIPSCs amplitude. 
The bar indicates the time of sulprostone (EP3 agonist) application. (c) Summary time-
course of eIPSCs amplitude (light brown), PPR (red), and 1/CV2 (light purple). 
Sulprostone decreased the amplitude of the eIPSCs (0-5 min vs. 10-15 min, p = 0.08, n 
= 5) The horizontal bar represents the time of sulprostone (EP3 agonist) application. 
Data are mean ± s.e.m. 
a 
b 
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Figure 3-13. Psychological restraint stress modulates PGE2-mediated 
attenuation of the GABA release. (a) Percent change in eIPSCs amplitude from the 
baseline after application of the PGE2 in naïve (red), 1 day stressed (pink), and 5 day 
stressed (dark brown) animals. (b) Percent change in eIPSCs amplitude after application 
of the sulprostone (EP3 agonist) in naïve (blue), 1 day stressed (purple), and 5 day 
stressed (light brown) animals. 
a b 
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4   Discussion 
The primary goal of this study was to identify the mechanisms by which PGE2 
activates PNCs in the PVN with relevance to the activation of the HPA axis during 
inflammation. To this end, I focused on how PGE2 modulates GABAergic synaptic inputs 
onto PNCs, as the removal of GABA-mediated inhibition (i.e. disinhibition) is an 
established neuronal mechanisms that drives PNC activity and ensuing HPA axis outputs 
(Verkuyl et al., 2004; Hewitt et al., 2009; Sarkar et al., 2011; Bains et al., 2015). The first 
part of my thesis established that PGE2 robustly attenuates GABAergic transmission onto 
PNCs and demonstrated its presynaptic locus inhibiting the release of GABA. The second 
part identified that EP3 receptors are responsible for  PGE2-mediated inhibition of GABA 
release. These results collectively identified a plausible mechanism by which PGE2 
activates PNCs, and as a consequence the HPA axis. In the final part of my thesis, I 
explored whether a preceding psychological stress modulates the PGE2-induced 
suppression of GABA synaptic transmission, in an effort to uncover synaptic mechanisms 
by which an exposure to psychological stress changes the sensitivity of the HPA axis to 
inflammation (Jd et al., 2002). I found that following an acute as well as sub-chronic 
psychological stress exposure, the inhibitory effects of PGE2 on GABA synaptic 
transmission becomes highly variable, some even resulting in an opposite potentiation of 
GABAergic transmission. I obtained evidence that the potentiation of GABA synapse is 
mediated by EP receptors other than EP3 (i.e. EP1, EP2 or EP4), which only became 
evident following psychological stress. Thus, my results suggest a potential synaptic 
mechanism where psychological stress modulates the sensitivity of the HPA axis to 
inflammatory stress signal PGE2.  
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4.1   PGE2 suppresses GABAergic synaptic inputs onto PNCs. 
It is well documented that the central actions of PGE2 mediate the activation of the 
HPA axis in response to systemic inflammation (Morimoto et al., 1989; Murakami and 
Watanabe, 1989; Rivier and Vale, 1991). My thesis examined the GABAergic synapses 
onto PNCs as a potential target of PGE2 action and found that PGE2 robustly suppressed 
GABAergic transmission to PNCs. Specifically, I showed that PGE2 dose-dependently 
decreases the amplitude of the eIPSCs recorded in PNCs in acute brain slices, and the 
effects of PGE2 have a rapid onset (< 5 min) after the application of the drug and are long 
lasting (< 20 min) after the wash out. My finding extended previous electrophysiological 
studies by Ferri and Ferguson reporting that both IL-1β (a cytokine that stimulates PGE2 
synthesis) and PGE2 supressed spontaneous GABAergic synaptic transmission to PNCs of 
the PVN (Ferri and Ferguson, 2003; Ferri et al., 2005). Also, in line with our results, it has 
been  shown that GABAA receptor antagonist bicuculline occluded IL-1β-induced 
activation of the parvocellular neurons in ex vivo slice electrophysiology, indicating that a 
disinhibition of PNCs is a major mechanism underlying the activation of PNCs in response 
to inflammatory stimuli (Ferri et al., 2005). Based on my findings and those by others, I 
propose that disinhibition (a decreases in GABAA receptor inhibitory effects) is one 
important mechanism by which PGE2 activates PNCs and consequently the HPA axis.   
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4.2   PGE2-mediated GABA synapse depression involves 
presynaptic mechanisms. 
The major finding of my thesis is that PGE2 suppressed GABAergic synaptic 
transmission by decreasing Pr from the presynaptic terminals. The evidence that support 
this conclusion is two fold: first, we observed that the PGE2-mediated suppression of 
eIPSC amplitude is accompanied by an increase in PPR as well as a decrease in 1/CV2 
(Figure 3-3. a), well-established changes in synaptic parameters indicative of the decrease 
in Pr (Zucker and Regehr, 2002). Indeed, the eIPSC amplitude changes showed strong 
negative and positive correlations with the changes in PPR and 1/CV2, respectively (Figure 
3-3. b). Second, I found that PGE2 decreases the frequency of sIPSCs with no change in 
the amplitude. These results are again in line with the decrease in the release probability 
and also indicate that PGE2 had little, if any, effects on the quantal size (i.e. postsynaptic 
receptor expression and function).  
I found that the effect of PGE2 on sIPSCs was maintained in presence of TTX (an 
antagonist for voltage-dependent Na+ channels), indicating that PGE2 decreases the 
release of neurotransmitter independent of action potential firing. In the supraoptic nucleus 
of the hypothalamus, a previous study has shown that PGE2 similarly decreases the 
synaptic release of GABA in the presence of TTX (Ibrahim et al., 1999). Action potential-
dependent and -independent synaptic transmission are mediated in large part by 
overlapping molecular machinery regulating neurotransmitter release. However, there is a 
growing appreciation that there are small, but distinct, populations of synapses specifically 
involved in action potential-independent synaptic transmission (Ramirez and Kavalali, 
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2011)  and that some neuromodulators specifically modulate distinct types of synaptic 
transmission (Taniguchi et al., 2000; Glitsch, 2006). Our finding that PGE2 inhibits both 
eIPSCs and mIPSCs, with equal potency, suggesting that PGE2 targets neurotransmitter 
release mechanism common in both types of synapses and/or nonspecifically both types of 
synapses. In contrast to our finding of the PGE2 actions on action potential-independent 
mIPSCs, Ferri and Ferguson reported that PGE2-mediated suppression of the GABA 
release was abolished in presence of TTX, suggesting that the effect of the PGE2 is action 
potential-dependent (Ferri and Ferguson, 2005). This discrepancy may originate from 
slight difference in aCSF Ca+2 concentration (2.5 mM in our experiment, 2 mM in Ferri 
and Ferguson study) and also thickness of brain slices (300 µm in our study, 400  µm in 
Ferri and Ferguson study). In addition, in our experiments, voltage-clamp was performed 
for the majority of the recordings, whereas they recorded from the cells using current-
clamp configuration. Nevertheless, we do not have a solid explanation for this discrepancy. 
4.3   EP3 receptor mediates the inhibition of GABA release 
onto PNCs.  
Using mice lacking respective PGE2 receptors (EP1-EP4), Matsuoka et al., have 
shown that both EP1 and EP3-deficient mice showed an impaired HPA axis response to 
systemic LPS administration (Matsuoka et al., 2003). These findings indicate that both EP1 
and EP3 are necessary for PGE2-mediated activation of the HPA axis. My results 
demonstrate that EP3 mediates the inhibitory effects of PGE2 on GABAergic synaptic 
transmission, suggesting that the role of EP3 in the HPA axis likely involve its actions in 
the PVN GABA synapses. Consistent with the presynaptic locus of PGE2 action as 
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discussed above, the observed EP3-mediated GABA synapse inhibition was accompanied 
by the changes in synaptic parameters (PPR, 1/CV2, sIPSC frequency & amplitude). In line 
with our findings, histological studies have shown that EP3 proteins are highly expressed 
in the axonal terminals of the PVN but not in the cell bodies of postsynaptic neurons 
(Nakamura et al., 2000). Similarly, EP3 mRNA are highly expressed in brain regions 
known to send GABAergic inputs to the PVN (BNST, DMH, preoptic area (POA)) but 
only little, if any, in the PVN (Ek et al., 2000).  
It has also been shown that EP3 receptors are indispensable for febrile response to 
PGE2 (Ushikubi et al., 1998). The POA is the major site in the brain involved in illness-
induced fever. EP3-expressing POA neurones are GABAergic and are shown to project 
directly to the PVN (Nakamura et al., 2000, 2002; Ulrich-Lai and Herman, 2009). Thus, it 
has been proposed that PGE2 mediates fever response through suppression of these 
neurones. Additionally, similar to PGE2, local microinjection of the muscimol (GABAA 
receptors agonist) into the POA increases body temperature (Nakamura et al., 2002). These 
findings raise a possibility that the mechanism by which EP3 activates PNCs might be 
similar to EP3-mediated fever response.  
Furthermore, PGE2 also depolarises putative pre-autonomic neurons in the PVN 
that subsequently increase the sympathetic tone. Interestingly, PGE2-mediated 
sympathetic activation is modulated by EP3 receptors (Zhang et al., 2011). 
4.3.1   EP3 Gαi/o-GPCR signaling and synaptic transmission 
As I discussed earlier in this thesis, the EP3 receptor is a GPCR coupled with Gαi/o 
that inhibits adenylyl cyclase and decreases downstream cAMP signaling. A wide variety 
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of Gi-coupled GPCR, when expressed in the presynaptic terminals, decrease 
neurotransmitter release and synaptic efficacy (Atwood et al., 2014). Mechanistically, a 
decrease in the intracellular cAMP and subsequent reduction in the activity of the protein 
kinase A (PKA) have been linked to the inhibition of presynaptic voltage-dependent Ca+2 
channels (VDCCs). The inhibition of the VDCCs results in reduced vesicle docking and 
probability of neurotransmitter release (Mato et al., 2008; Atwood et al., 2014). For 
example, using patch-clamp electrophysiology, it has been reported that application of a 
VDCCs blocker (cadmium chloride) occludes CB1R Gαi/o-GPCR mediated suppression of 
the fast GABAergic synaptic transmission in rats pyramidal neurons suggesting that the 
effect of CB1 receptors on GABA release is likely due to inhibition of the VDCCs 
(Hoffman and Lupica, 2000). Similarly, mGluR7 Gαi/o-GPCR mediated LTD (long term 
depression) induced in mossy fiber (MF) synapses onto hippocampus stratum lucidum 
following high frequency stimulation (HFS) requires inhibition of the VDCCs (Pelkey et 
al., 2006). Together, these findings suggest that EP3 mediated suppression of GABA 
release could be likely be due to the inhibition of the VDCCs. However, further 
experiments need to be done to identify the precise mechanisms. 
4.3.2   The origins of EP3-expressing GABAergic inputs to PNCs 
My data indicates that presynaptic EP3 receptors suppress the release of the 
neurotransmitter from the local GABAergic neurons projecting to the PVN. However, the 
origin of these EP3 receptors-expressing GABAergic inputs remains to be identified. It has 
been shown that the anterior perifornical area, which is in some cases considered as part of 
the BNST, is one of the local GABAergic regions projecting to the PVN (Roland and 
Sawchenko, 1993). Histological studies from two independent labs have shown that the 
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anterior perifornical area highly expresses EP3 receptor mRNA and protein (Ek et al., 
2000b; Nakamura et al., 2000). Together, we speculate that the anterior perifornical area 
might be one of the major origins for GABAergic inputs on the PVN in response to PGE2 
application. 
4.4   PGE2 contributes to the HPA axis activation via non-
GABA mechanisms.  
My data indicate that PGE2 activates the HPA axis via the EP3 receptor-mediated 
suppression of GABAergic synaptic transmission. However, in parallel or in concert with 
this mechanism, there likely to be other mechanisms through which PGE2 drives the HPA 
axis. As discussed earlier, an EP receptor KO mice study indicated that besides EP3, EP1 
receptor mediates PGE2 effects on the HPA axis (Matsuoka et al., 2003). The neuronal 
mechanisms downstream of EP1 receptor activation remain unknown. Moreover, another 
in vivo study has shown that indomethacin (PG synthesis inhibitor) abolished IL-1β-
induced noradrenaline (NA) releases in the hypothalamus, indicating the role of PGE2 in 
NA release during inflammation (Tsumori et al., 1998). Indeed, PVN PNCs receive dense 
noradrenergic inputs from the nucleus of the solitary tract (NTS) in the brain stem 
(Cunningham and Sawchenko, 1988; Pacák, 2000) that are critical for inflammation-
induced activation of the HPA axis (Dunn, 1988; Terao et al., 1993). The NTS NA 
adrenergic neurons are believed to receive visceral sensory information including 
peripheral inflammatory signals to promote HPA axis rapid response to immediate 
physiological challenge (Herman et al., 2003, 2016). These findings raise a possibility that 
in parallel with GABA, PGE2 drives NAergic inputs onto PNCs for the activation of the 
HPA axis. Interestingly, it has also been shown that pharmacological blockade of COX-1 
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and COX-2 (PG synthesizing enzymes) decreased NA-induced activation of the HPA axis 
(Bugajski, 1996; Bugajski et al., 2001), pointing to a roles of PGE2 downstream of NA, 
and thus potential bidirectional interaction between PGE2 and NA signaling .  
4.5   Psychological stress impairs PGE2-mediated suppression 
of GABA release.  
Our results demonstrated that both single and repeated restraint stress impaired 
PGE2-induced suppression of the GABA release, suggesting that preceding psychological 
stress may decrease the excitatory effect of the PGE2 on parvocellular neuroendocrine 
cells. Somewhat surprisingly, however, we found that EP3 agonist still significantly 
suppressed GABA release to a similar extent as in slices from naïve rats. This suggested 
that EP receptors other than EP3 cancelled out the inhibitory effects of EP3 and that such 
mechanisms were unmasked by psychological stress. Indeed, when we examined the 
individual synaptic response to PGE2 following stress, we observed that the preceding 
psychological stress increased the variability in the synaptic responses: that is, PGE2 
caused depression (as effective as in the case of stress naïve slices) in some synapses 
whereas it caused an opposite potentiation in other synapses (Figure 3-13). Thus, one 
interpretation would be that after psychological stress EP receptors other than EP3 drove 
PGE2-induced potentiation of the GABA release. EP2 and EP4 are coupled to G protein 
stimulatory α subunit (Gsα) that activate adenylyl cyclase and facilitate neurotransmitter 
release (Furuyashiki and Narumiya, 2011; Betke et al., 2012). It has been shown that EP4 
mRNA is highly expressed in the PVN (Zhang and Rivest, 1999). Taken together, we 
speculate that EP4 receptors might be involved in PGE2-mediated potentiation of the 
GABA release. 
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4.6   Conclusion and significance 
 This study investigated the synaptic mechanism by which PGE2 excites PVN PNCs 
and ultimately the HPA axis. My data showed that, PGE2 attenuated the GABAergic 
synaptic transmission onto PNCs: this indicated that disinhibition could be one mechanism 
by which PGE2 increased the excitability of the PNCs. Further, in depth analysis of the 
changes in PGE2-induced synaptic plasticity revealed a presynaptic locus of PGE2 action 
where EP3 receptor activation suppressed the release of GABA from the presynaptic 
terminals. I also found that psychological stress impaired PGE2-induced suppression of 
GABAergic inputs onto PNCs. This is likely due to the recruitment of EP receptors other 
than EP3 that potentiated GABA synapse, whereas EP3-mediated GABA release 
suppression was insensitive to psychological stress. 
In response to systemic inflammation, PGE2 is produced in the brain, exerts various 
physiological and psychological actions one of which is activation of the HPA axis 
(Furuyashiki and Narumiya, 2011). The results from this study provide one possible 
mechanism by which PGE2 regulates HPA axis response. Importantly, activation of the 
HPA axis and the releases of glucocorticoids play critical roles in controlling the 
inflammatory response and thereby preventing overactive immune response such as septic 
shock (Silverman et al., 2005). Thus, our findings may ultimately be helpful for future 
research trying to unravel the mechanisms involved in life-threatening diseases such as 
endotoxemia or sepsis. 
 
 
 60 
5   References 
 
Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune 
response. Nature 406:782–787. 
Alexander C, Rietschel ET (2001) Bacterial lipopolysaccharides and innate immunity. J 
Endotoxin Res 7:167–202. 
Amiry-Moghaddam M, Ottersen OP (2003) The molecular basis of water transport in the 
brain. Nat Rev Neurosci 4:991–1001. 
Atwood BK, Lovinger DM, Mathur BN (2014) Presynaptic long-term depression 
mediated by Gi/o-coupled receptors. Trends Neurosci 37:663–673. 
Bains JS, Wamsteeker Cusulin JI, Inoue W (2015) Stress-related synaptic plasticity in the 
hypothalamus. Nat Rev Neurosci 16:377–388. 
Barton GM (2008) A calculated response: control of inflammation by the innate immune 
system. J Clin Invest 118:413–420. 
Bazemore AW, Elliott K a. C, Florey E (1957) Isolation of Factor I. J Neurochem 1:334–
339. 
Ben-Ari Y (2002) Excitatory actions of gaba during development: the nature of the 
nurture. Nat Rev Neurosci 3:728–739. 
Benarroch EE (2005) Paraventricular nucleus, stress response, and cardiovascular 
disease. Clin Auton Res 15:254–263. 
Betke KM, Wells CA, Hamm HE (2012) GPCR mediated regulation of synaptic 
transmission. Prog Neurobiol 96:304–321. 
Branco T, Staras K (2009) The probability of neurotransmitter release: variability and 
feedback control at single synapses. Nat Rev Neurosci 10:373–383. 
Breder CD, Saper CB (1996) Expression of inducible cyclooxygenase mRNA in the 
mouse brain after systemic administration of bacterial lipopolysaccharide. Brain 
Res 713:64–69. 
Bugajski J (1996) Role of prostaglandins in the stimulation of the hypothalamic-pituitary-
adrenal axis by adrenergic and neurohormone systems. J Physiol Pharmacol Off J 
Pol Physiol Soc 47:559–575. 
Bugajski J, Głód R, Gadek-Michalska A, Bugajski AJ (2001) Involvement of constitutive 
(COX-1) and inducible cyclooxygenase (COX-2) in the adrenergic-induced 
 61 
ACTH and corticosterone secretion. J Physiol Pharmacol Off J Pol Physiol Soc 
52:795–809. 
Buller K, Xu Y, Dayas C, Day T (2001) Dorsal and ventral medullary catecholamine cell 
groups contribute differentially to systemic interleukin-1beta-induced 
hypothalamic pituitary adrenal axis responses. Neuroendocrinology 73:129–138. 
Cao C, Matsumura K, Yamagata K, Watanabe Y (1996) Endothelial cells of the rat brain 
vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-
1β: a possible site of prostaglandin synthesis responsible for fever. Brain Res 
733:263–272. 
Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 
5:374–381. 
Cole RL, Sawchenko PE (2002) Neurotransmitter regulation of cellular activation and 
neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. 
J Neurosci Off J Soc Neurosci 22:959–969. 
Cui L-N, Coderre E, Renaud LP (2001) Glutamate and GABA mediate suprachiasmatic 
nucleus inputs to spinal-projecting paraventricular neurons. Am J Physiol - Regul 
Integr Comp Physiol 281:R1283–R1289. 
Cullinan WE, Wolfe TJ (2000) Chronic stress regulates levels of mRNA transcripts 
encoding beta subunits of the GABA(A) receptor in the rat stress axis. Brain Res 
887:118–124. 
Cullinan WE, Ziegler DR, Herman JP (2008) Functional role of local GABAergic 
influences on the HPA axis. Brain Struct Funct 213:63–72. 
Cunningham ET, Sawchenko PE (1988) Anatomical specificity of noradrenergic inputs 
to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp 
Neurol 274:60–76. 
de Kloet ER, Joëls M, Holsboer F (2005) Stress and the brain: from adaptation to disease. 
Nat Rev Neurosci 6:463–475. 
Dunn AJ (1988) Systemic interleukin-1 administration stimulates hypothalamic 
norepinephrine metabolism parallelling the increased plasma corticosterone. Life 
Sci 43:429–435. 
Ek M, Arias C, Sawchenko P, Ericsson-Dahlstrand A (2000a) Distribution of the EP3 
prostaglandin E2 receptor subtype in the rat brain: Relationship to sites of 
interleukin-1–induced cellular responsiveness. J Comp Neurol 428:5–20. 
Ek M, Arias C, Sawchenko P, Ericsson-Dahlstrand A (2000b) Distribution of the EP3 
prostaglandin E2 receptor subtype in the rat brain: Relationship to sites of 
interleukin-1–induced cellular responsiveness. J Comp Neurol 428:5–20. 
 62 
Elenkov IJ, Chrousos GP (1999) Stress Hormones, Th1/Th2 patterns, Pro/Anti-
inflammatory Cytokines and Susceptibility to Disease. Trends Endocrinol Metab 
10:359–368. 
Elliott KAC, Flow E (1956) FACTOR I—INHIBITORY FACTOR FROM BRAIN. J 
Neurochem 1:181–191. 
Ferri CC, Ferguson AV (2003) Interleukin-1β Depolarizes Paraventricular Nucleus 
Parvocellular Neurones. J Neuroendocrinol 15:126–133. 
Ferri CC, Ferguson AV (2005) Prostaglandin E2 mediates cellular effects of interleukin-
1beta on parvocellular neurones in the paraventricular nucleus of the 
hypothalamus. J Neuroendocrinol 17:498–508. 
Ferri CC, Yuill EA, Ferguson AV (2005) Interleukin-1beta depolarizes magnocellular 
neurons in the paraventricular nucleus of the hypothalamus through 
prostaglandin-mediated activation of a non selective cationic conductance. Regul 
Pept 129:63–71. 
Finsterwald C, Alberini CM (2014) Stress and glucocorticoid receptor-dependent 
mechanisms in long-term memory: from adaptive responses to psychopathologies. 
Neurobiol Learn Mem 0:17–29. 
Furuyashiki T, Narumiya S (2009) Roles of prostaglandin E receptors in stress responses. 
Curr Opin Pharmacol 9:31–38. 
Furuyashiki T, Narumiya S (2011) Stress responses: the contribution of prostaglandin 
E(2) and its receptors. Nat Rev Endocrinol 7:163–175. 
García-Bueno B, Serrats J, Sawchenko PE (2009) Cerebrovascular cyclooxygenase-1 
expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation 
by inflammatory stimuli. J Neurosci Off J Soc Neurosci 29:12970–12981. 
Glitsch M (2006) Selective inhibition of spontaneous but not Ca2+ -dependent release 
machinery by presynaptic group II mGluRs in rat cerebellar slices. J Neurophysiol 
96:86–96. 
Griffin JB (1990) Psychological Disturbances of Vegetative Function. In: Clinical 
Methods: The History, Physical, and Laboratory Examinations, 3rd ed. (Walker 
HK, Hall WD, Hurst JW, eds). Boston: Butterworths. Available at: 
http://www.ncbi.nlm.nih.gov/books/NBK318/ [Accessed February 22, 2017]. 
Gwosdow AR, Kumar MS, Bode HH (1990) Interleukin 1 stimulation of the 
hypothalamic-pituitary-adrenal axis. Am J Physiol 258:E65-70. 
Hench PS, Kendall EC, Slocumb CH, Polley HF (1949) Adrenocortical Hormone in 
Arthritis *. Ann Rheum Dis 8:97–104. 
 63 
Herman JP, Cullinan WE (1997) Neurocircuitry of stress: central control of the 
hypothalamo–pituitary–adrenocortical axis. Trends Neurosci 20:78–84. 
Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan 
WE (2003) Central mechanisms of stress integration: hierarchical circuitry 
controlling hypothalamo-pituitary-adrenocortical responsiveness. Front 
Neuroendocrinol 24:151–180. 
Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, Scheimann J, 
Myers B (2016) Regulation of the hypothalamic-pituitary-adrenocortical stress 
response. Compr Physiol 6:603–621. 
Hewitt SA, Wamsteeker JI, Kurz EU, Bains JS (2009) Altered chloride homeostasis 
removes synaptic inhibitory constraint of the stress axis. Nat Neurosci 12:438–
443. 
Hoffman AF, Lupica CR (2000) Mechanisms of Cannabinoid Inhibition of 
GABAASynaptic Transmission in the Hippocampus. J Neurosci 20:2470–2479. 
Ibrahim N, Shibuya I, Kabashima N, Sutarmo SV, Ueta Y, Yamashita H (1999) 
Prostaglandin E2 inhibits spontaneous inhibitory postsynaptic currents in rat 
supraoptic neurones via presynaptic EP receptors. J Neuroendocrinol 11:879–886. 
Jansen ASP, Van Nguyen X, Karpitskiy V, Mettenleiter TC, Loewy AD (1995) Central 
Command Neurons of the Sympathetic Nervous System: Basis of the Fight-or-
Flight Response. Science 270:644–646. 
Jc S, Pe S (2003) Signaling the brain in systemic inflammation: the role of perivascular 
cells. Front Biosci J Virtual Libr 8:s1321-9. 
Jd J, Ka O, T D, Rl S, Lr W, Sf M (2002) Prior stressor exposure primes the HPA axis. 
Psychoneuroendocrinology 27:353–365. 
Johnson EO, Kamilaris TC, Chrousos GP, Gold PW (1992) Mechanisms of stress: A 
dynamic overview of hormonal and behavioral homeostasis. Neurosci Biobehav 
Rev 16:115–130. 
Kalinski P (2012) Regulation of immune responses by prostaglandin E2. J Immunol 
Baltim Md 1950 188:21–28. 
Kapcala LP, Chautard T, Eskay RL (1995) The protective role of the hypothalamic-
pituitary-adrenal axis against lethality produced by immune, infectious, and 
inflammatory stress. Ann N Y Acad Sci 771:419–437. 
Katsuura G, Arimura A, Koves K, Gottschall PE (1990) Involvement of organum 
vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced 
ACTH release. Am J Physiol 258:E163-171. 
 64 
Kaufman DL, Houser CR, Tobin AJ (1991) Two Forms of the γ-Aminobutyric Acid 
Synthetic Enzyme Glutamate Decarboxylase Have Distinct Intraneuronal 
Distributions and Cofactor Interactions. J Neurochem 56:720–723. 
Kiss JZ, Martos J, Palkovits M (1991) Hypothalamic paraventricular nucleus: A 
quantitative analysis of cytoarchitectonic subdivisions in the rat. J Comp Neurol 
313:563–573. 
Konsman JP, Parnet P, Dantzer R (2002) Cytokine-induced sickness behaviour: 
mechanisms and implications. Trends Neurosci 25:154–159. 
Korn H, Faber DS (1991) Quantal analysis and synaptic efficacy in the CNS. Trends 
Neurosci 14:439–445. 
Leng G, Brown CH, Russell JA (1999) Physiological pathways regulating the activity of 
magnocellular neurosecretory cells. Prog Neurobiol 57:625–655. 
Li HY, Ericsson A, Sawchenko PE (1996) Distinct mechanisms underlie activation of 
hypothalamic neurosecretory neurons and their medullary catecholaminergic 
afferents in categorically different stress paradigms. Proc Natl Acad Sci 93:2359–
2364. 
Lovick TA, Malpas S, Mahony MT (1993) Renal vasodilatation in response to acute 
volume load is attenuated following lesions of parvocellular neurones in the 
paraventricular nucleus in rats. J Auton Nerv Syst 43:247–255. 
Lupien SJ, Maheu F, Tu M, Fiocco A, Schramek TE (2007) The effects of stress and 
stress hormones on human cognition: Implications for the field of brain and 
cognition. Brain Cogn 65:209–237. 
Luscher B, Shen Q, Sahir N (2011) The GABAergic deficit hypothesis of major 
depressive disorder. Mol Psychiatry 16:383–406. 
Luther JA, Daftary SS, Boudaba C, Gould GC, Halmos KC, Tasker JG (2002) 
Neurosecretory and Non-Neurosecretory Parvocellular Neurones of the 
Hypothalamic Paraventricular Nucleus Express Distinct Electrophysiological 
Properties. J Neuroendocrinol 14:929–932. 
Luther JA, Halmos KC, Tasker JG (2000) A Slow Transient Potassium Current 
Expressed in a Subset of Neurosecretory Neurons of the Hypothalamic 
Paraventricular Nucleus. J Neurophysiol 84:1814–1825. 
Maguire J (2014) Stress-induced plasticity of GABAergic inhibition. Front Cell Neurosci 
8 Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047962/ 
[Accessed March 18, 2017]. 
Makara GB, Stark E (2004) Effect of Gamma-Aminobutyric Acid (GABA) and GABA 
Antagonist Drugs on ACTH Release. Neuroendocrinology 16:178–190. 
 65 
Martin DL, Rimvall K (1993) Regulation of gamma-aminobutyric acid synthesis in the 
brain. J Neurochem 60:395–407. 
Mato S, Lafourcade M, Robbe D, Bakiri Y, Manzoni OJ (2008) Role of the cyclic-
AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated 
long-term depression in the nucleus accumbens. Neuropharmacology 54:87–94. 
Matsuoka Y, Furuyashiki T, Bito H, Ushikubi F, Tanaka Y, Kobayashi T, Muro S, Satoh 
N, Kayahara T, Higashi M, Mizoguchi A, Shichi H, Fukuda Y, Nakao K, 
Narumiya S (2003a) Impaired adrenocorticotropic hormone response to bacterial 
endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. 
Proc Natl Acad Sci U S A 100:4132–4137. 
Matsuoka Y, Furuyashiki T, Bito H, Ushikubi F, Tanaka Y, Kobayashi T, Muro S, Satoh 
N, Kayahara T, Higashi M, Mizoguchi A, Shichi H, Fukuda Y, Nakao K, 
Narumiya S (2003b) Impaired adrenocorticotropic hormone response to bacterial 
endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. 
Proc Natl Acad Sci U S A 100:4132–4137. 
Medzhitov R, Janeway C (2000) Innate immunity. N Engl J Med 343:338–344. 
Miklós IH, Kovács KJ (2002) GABAergic innervation of corticotropin-releasing 
hormone (CRH)-secreting parvocellular neurons and its plasticity as demonstrated 
by quantitative immunoelectron microscopy. Neuroscience 113:581–592. 
Milton NG, Hillhouse EW, Milton AS (1992) Activation of the hypothalamo-pituitary-
adrenocortical axis in the conscious rabbit by the pyrogen 
polyinosinic:polycytidylic acid is dependent on corticotrophin-releasing factor-41. 
J Endocrinol 135:69–75. 
Mogensen TH (2009) Pathogen Recognition and Inflammatory Signaling in Innate 
Immune Defenses. Clin Microbiol Rev 22:240–273. 
Morimoto A, Murakami N, Nakamori T, Sakata Y, Watanabe T (1989) Possible 
involvement of prostaglandin E in development of ACTH response in rats 
induced by human recombinant interleukin-1. J Physiol 411:245–256. 
Murakami N, Watanabe T (1989) Activation of ACTH release is mediated by the same 
molecule as the final mediator, PGE2, of febrile response in rats. Brain Res 
478:171–174. 
Nakamura K, Kaneko T, Yamashita Y, Hasegawa H, Katoh H, Negishi M (2000) 
Immunohistochemical localization of prostaglandin EP3 receptor in the rat 
nervous system. J Comp Neurol 421:543–569. 
Nakamura K, Matsumura K, Kaneko T, Kobayashi S, Katoh H, Negishi M (2002) The 
rostral raphe pallidus nucleus mediates pyrogenic transmission from the preoptic 
area. J Neurosci Off J Soc Neurosci 22:4600–4610. 
 66 
Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, 
and functions. Physiol Rev 79:1193–1226. 
Nathan C (2002) Points of control in inflammation. Nature 420:846–852. 
Nunn N, Womack M, Dart C, Barrett-Jolley R (2011) Function and Pharmacology of 
Spinally-Projecting Sympathetic Pre-Autonomic Neurones in the Paraventricular 
Nucleus of the Hypothalamus. Curr Neuropharmacol 9:262–277. 
Oka T, Oka K, Scammell TE, Lee C, Kelly JF, Nantel F, Elmquist JK, Saper CB (2000) 
Relationship of EP(1-4) prostaglandin receptors with rat hypothalamic cell groups 
involved in lipopolysaccharide fever responses. J Comp Neurol 428:20–32. 
Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of 
gamma-aminobutyric acid(A) receptors: classification on the basis of subunit 
composition, pharmacology, and function. Update. Pharmacol Rev 60:243–260. 
Owens DF, Kriegstein AR (2002) Is there more to gaba than synaptic inhibition? Nat Rev 
Neurosci 3:715–727. 
Pacák K (2000) Stressor-specific activation of the hypothalamic-pituitary-adrenocortical 
axis. Physiol Res 49 Suppl 1:S11-17. 
Patel KP (2000) Role of Paraventricular Nucleus in Mediating Sympathetic Outflow in 
Heart Failure. Heart Fail Rev 5:73–86. 
Patel KP, Zhang K (1996) NEUROHUMORAL ACTIVATION IN HEART FAILURE: 
ROLE OF PARAVENTRICULAR NUCLEUS. Clin Exp Pharmacol Physiol 
23:722–726. 
Pelkey KA, Topolnik L, Lacaille J-C, McBain CJ (2006) Compartmentalized Ca2+ 
Channel Regulation at Divergent Mossy-Fiber Release Sites Underlies Target 
Cell-Dependent Plasticity. Neuron 52:497–510. 
Quan N, Whiteside M, Herkenham M (1998) Cyclooxygenase 2 mRNA expression in rat 
brain after peripheral injection of lipopolysaccharide. Brain Res 802:189–197. 
Ramirez DMO, Kavalali ET (2011) Differential Regulation of Spontaneous and Evoked 
Neurotransmitter Release at Central Synapses. Curr Opin Neurobiol 21:275–282. 
Reul JM, de Kloet ER (1985) Two receptor systems for corticosterone in rat brain: 
microdistribution and differential occupation. Endocrinology 117:2505–2511. 
Rivest S, Rivier C (1994) Stress and Interleukin-1 β-Induced Activation of c-fos, NGFI-B 
ann CRF Gene Expression in the Hypothalamic PVN: Comparison Between 
Sprague-Dawley, Fisher-344 and Lewis Rats. J Neuroendocrinol 6:101–117. 
 67 
Rivier C, Vale W (1991) Stimulatory effect of interleukin-1 on adrenocorticotropin 
secretion in the rat: is it modulated by prostaglandins? Endocrinology 129:384–
388. 
Roland BL, Sawchenko PE (1993) Local origins of some GABAergic projections to the 
paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp 
Neurol 332:123–143. 
Ruzek MC, Pearce BD, Miller AH, Biron CA (1999) Endogenous Glucocorticoids 
Protect Against Cytokine-Mediated Lethality During Viral Infection. J Immunol 
162:3527–3533. 
Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W (1987) Interleukin-1 stimulates 
the secretion of hypothalamic corticotropin-releasing factor. Science 238:522–
524. 
Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress 
responses? Integrating permissive, suppressive, stimulatory, and preparative 
actions. Endocr Rev 21:55–89. 
Sarkar J, Wakefield S, MacKenzie G, Moss SJ, Maguire J (2011) Neurosteroidogenesis is 
required for the physiological response to stress: role of neurosteroid-sensitive 
GABAA receptors. J Neurosci Off J Soc Neurosci 31:18198–18210. 
Schiltz JC, Sawchenko PE (2002) Distinct brain vascular cell types manifest inducible 
cyclooxygenase expression as a function of the strength and nature of immune 
insults. J Neurosci Off J Soc Neurosci 22:5606–5618. 
Silverman MN, Pearce BD, Biron CA, Miller AH (2005) Immune modulation of the 
hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol 
18:41–78. 
Smith SM, Vale WW (2006) The role of the hypothalamic-pituitary-adrenal axis in 
neuroendocrine responses to stress. Dialogues Clin Neurosci 8:383–395. 
Somogyi P, Tamás G, Lujan R, Buhl EH (1998) Salient features of synaptic organisation 
in the cerebral cortex1. Brain Res Rev 26:113–135. 
Stern JE (2001) Electrophysiological and morphological properties of pre-autonomic 
neurones in the rat hypothalamic paraventricular nucleus. J Physiol 537:161–177. 
Stern JE (2015) Neuroendocrine-Autonomic Integration in the Paraventricular Nucleus: 
Novel Roles for Dendritically Released Neuropeptides. J Neuroendocrinol 
27:487–497. 
Sugimoto Y, Narumiya S (2007) Prostaglandin E Receptors. J Biol Chem 282:11613–
11617. 
 68 
Swanson LW, Sawchenko PE (1983) Hypothalamic integration: organization of the 
paraventricular and supraoptic nuclei. Annu Rev Neurosci 6:269–324. 
Taniguchi N, Takada N, Kimura F, Tsumoto T (2000) Actions of brain-derived 
neurotrophic factor on evoked and spontaneous EPSCs dissociate with maturation 
of neurones cultured from rat visual cortex. J Physiol 527:579–592. 
Tao YH, Yuan Z, Tang XQ, Xu HB, Yang XL (2006) Inhibition of GABA shunt 
enzymes’ activity by 4-hydroxybenzaldehyde derivatives. Bioorg Med Chem Lett 
16:592–595. 
Tasker JG, Dudek FE (1991) Electrophysiological properties of neurones in the region of 
the paraventricular nucleus in slices of rat hypothalamus. J Physiol 434:271–293. 
TASKER JG, HERMAN JP (2011) Mechanisms of rapid glucocorticoid feedback 
inhibition of the hypothalamic–pituitary–adrenal axis. Stress Amst Neth 14:398–
406. 
Terao A, Oikawa M, Saito M (1993) Cytokine-induced change in hypothalamic 
norepinephrine turnover: involvement of corticotropin-releasing hormone and 
prostaglandins. Brain Res 622:257–261. 
Tsumori C, Shibasaki T, Hotta M, Takeuchi K, Yamauchi N, Imaki T, Wakabayashi I, 
Demura H (1998) Interleukin-1beta administered intracerebroventricularly 
stimulates the release of noradrenaline in the hypothalamic paraventricular 
nucleus via prostaglandin in the rat. Endocr J 45:127–130. 
Ulrich-Lai YM, Herman JP (2009) Neural Regulation of Endocrine and Autonomic 
Stress Responses. Nat Rev Neurosci 10:397–409. 
Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T, Hizaki H, Tuboi 
K, Katsuyama M, Ichikawa A, Tanaka T, Yoshida N, Narumiya S (1998) 
Impaired febrile response in mice lacking the prostaglandin E receptor subtype 
EP3. Nature 395:281–284. 
Verkuyl JM, Hemby SE, Joëls M (2004) Chronic stress attenuates GABAergic inhibition 
and alters gene expression of parvocellular neurons in rat hypothalamus. Eur J 
Neurosci 20:1665–1673. 
Wei T, Lightman SL (1997) The neuroendocrine axis in patients with multiple sclerosis. 
Brain 120:1067–1076. 
Wu C, Sun D (2015) GABA receptors in brain development, function, and injury. Metab 
Brain Dis 30:367–379. 
Zhang J, Rivest S (1999) Distribution, regulation and colocalization of the genes 
encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal 
responses to systemic inflammation. Eur J Neurosci 11:2651–2668. 
 69 
Zhang Z-H, Yu Y, Wei S-G, Nakamura Y, Nakamura K, Felder RB (2011) EP₃ receptors 
mediate PGE₂-induced hypothalamic paraventricular nucleus excitation and 
sympathetic activation. Am J Physiol Heart Circ Physiol 301:H1559-1569. 
Zucker RS, Regehr WG (2002) Short-term synaptic plasticity. Annu Rev Physiol 64:355–
405. 
 
 
  
 70 
6   CURRICULUM VITAE 
EDUCATION 
 
 
•  M.Sc.  in Physiology and Pharmacology                                      January 2015 –April 2017 
•  Robarts  Research Institute                                                           
University of Western Ontario, London, Ontario,  
Supervisor: Dr. Wataru Inoue PhD 
•  Thesis Topic:  Synaptic Mechanisms for the Hypothalamic-Pituitary- Adrenal Axis 
Activation by Prostaglandin E2. 
 
•  Doctorate  of Medicine                                                              September 2003 – January 2011 
Zanjan University of Medical Science, Zanjan, Iran  
Supervisor: Professor Abdolkarim Sheikh  
Thesis Topic:  The effect of yogurt bacteria (Lactic acid) on pro/anti-inflammatory 
cytokine response of peripheral blood lymphocytes (PBLs) of ulcerative colitis patients.  
HONORS AND AWARDS 
 
•  Two-years  Western  Graduate  Research Scholarship (WGRS), C a n a d a  January 2015 
•  Thesis research award,  Zanjan  University of medical science, I r a n         September 2010  
•  Ranked 5th among all participants  in Zanjan  university, Iran                     February 2006  
In the nationwide comprehensive basic science exam for third year medical students. 
•  Ranked 730th among more than 500,000 participants,                               September 2003 
In the nationwide university entrance exam for undergraduate studies. 
•  Semi-finalist in National  Olympiad  in Chemistry, Iran,                 September 2002 
•  Ranked 1st among 60 students, Payamdanesh high school, Iran                        June 2002  
TEACHING EXPERIENCE 
 
•  Teaching Assistant 
Dentistry 5102, Dental Pharmacology                                      September 2016 – January 2017 
Schulich Dentistry, University of Western Ontario, London, Canada. 
Mamilian Physiology, 3120                                                        September 2016 – January 2017 
Schulich Dentistry, University of Western Ontario, London, Canada. 
VOLUNTEER 
 
•  Conference session host,                                                                                      May 2014 
Ontario University and College Health Association (OUCHA) conference 
                         
•  Volunteer in Emergency room of the hospital                           June 2013 – February 2014 
Grand River Hospital, Waterloo, Ontario, Canada. 
 71 
 
PUBLICATION and PRESENTATION 
 
 
•  Zahra Khazaeipool and Wataru Inoue. “Prostaglandin E2-mediated neuroendocrine stress 
response involves the attenuation of GABA release” In prepration. 
•  Simon Chiu, Michael Woodbury-Farina, Kristen Terpstra, Hana Raheb, Jurai Hou, Yves 
Bureau, Zack Cer- novsky, Mariwan Husni, John Copen, Ana Hategan, Ann Seeley Johnson, 
Josh Varghese, Zahra Khazaeipool, “Exploring the Architecture of Epigenetics in Alzheimers 
Dementia: Evidence Promises and Challenges” Chapter book, SM group (esciencemedicine), 
November 2016. 
•  Zahra Khazaeipool and Wataru Inoue. “Prostaglandin E2 drives neuroendocrine stress 
response through presynaptic inhibition of GABA release.”, Presented in Canadian 
Association for Neuroscience, May 2016, Toronto, Canada. 
•  Jessica Nicastro, Shirley Wong, Zahra Khazaeipool, Peggy Lam, Jonathan Blay, and 
Roderick Slavcev. “Bacteriophage Applications - Historical Perspective and Future Potential”, 
book, Springer, October 2016. 
•  Zahra Khazaeipool and Wataru Inoue. “The mechanism of Hypothalamus- Pituitary-Adrenal 
(HPA) Axis activation during inflammation”, Poster presentation in Southern Ontario 
NeuroscienceAssociation: SONA, May 2016, Waterloo, Canada 
